NFL quarterback Aaron Rodgers caused a stir in the US this week, when it emerged that he’d been keeping on the low pretending to be vaccinated from COVID-19 (when he wasn’t).

The news only came to light when Rodgers actually caught COVID-19, and was forced to stay away from the team due to his no-vax status.

Rodgers came under some heat from members of the media, who dialled into a sneaky press conference a few months prior when Rodgers said he’d been ‘immunised’ against the disease (for those playing at home; not the same).

In the ensuing controversy, Rodgers then appeared on the Pat McAfee podcast and had a go at cancel culture and indicated a preference for ivermectin (also used as a livestock dewormer) in battling the disease.

While the no-vax debate continues to rage (moreso, seemingly, in the US), ASX investors have been afflicted with ailments of a different kind (read on below).


Here are the best performing ASX small cap stocks for November 5 – November 12 [intraday]:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

In case you missed it on Stockhead this week, magnesium madness has taken hold and Latrobe Magnesium (ASX:LMG) is front and centre as investors pile into the sector.

After ripping higher earlier this week on no news, the stock jumped again this morning after announcing an oversubscribed $11.5m placement to sophisticated, professional and institutional investors that will fast-track the construction of its initial 1,000tpa magnesium plant in Latrobe Valley.

Shares in LMG have now risen by almost 800% since the start of the 2022 financial year.

Also posting a triple-digit percentage return this week was Environmental Clean Technologies (ASX:ECT), which rose by 130%.

The company has a number of clean energy technologies under development in lignite, hydrogen and waste conversion.

ECT shares often hop around and the stock has traded in a 12-month range between 1c and 2c — but this week it broke out (on no news).

Those gains may have had something to do with ECT’s hydrogen-based technologies, because next to magnesium madness, hydrogen fever has well and truly taken hold among small cap investors.

Also ripping higher was Pure Hydrogen (ASX:PH2), which this week signed a term-sheet with CAC-H2 to build Waste to Hydrogen plants in Brisbane, Sydney, and Melbourne.

CAC-H2 will “fund, build, and operate the plant and Pure Hydrogen will fund storage and load out”, the company said.

Hydrogen investment company Renu Energy (ASX:RNE) also surged ahead, after flagging the acquisition of green hydrogen technology developer Countrywide Renewable Hydrogen (CRH) in a $9.156m share-based deal.

Other notable movers this week included Bitcoin proxy DigitalX (ASX:DCC), which owns 215 Bitcoin on its balance sheet and has more than doubled since the start of October, from ~6c to 15.5c.


Here are the worst performing ASX small cap stocks for November 5 – November 12 [intraday]:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin